Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Differentiation State Plasticity As a Mechanism of BCL2 Inhibitor Resistance in Acute Myeloid Leukemia

William M Yashar, Mitsuhiro Tsuchiya, Akram Taherinasab, Sara Evans-Dutson, Brendan O'Connell, Theresa Lusardi, Nicole Szczepanksi, Galip Gurkan Yardimci, Andrew C Adey, Julia E Maxson, Theodore P Braun

Blood (2023) 142 (Supplement 1): 2786.

https://doi.org/10.1182/blood-2023-175057

Published: 2023

Journal Articles

Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R -driven myeloproliferative neoplasms

Sarah A. Carratt, Garth L. Kong, Brittany M. Curtiss, Zachary Schonrock, Lauren Maloney, Breanna N. Maniaci, Hunter Z. Blaylock, Adrian Baris, Brian J. Druker, Theodore P. Braun, Julia E. Maxson

Blood (2022) 140 (6): 644–658.

https://doi.org/10.1182/blood.2021014777

Published: 2022

Includes: Supplemental data

Journal Articles

A Novel CSF3R Activating Mutation Identified in a Patient with Chronic Neutrophilic Leukemia

Breanna Maniaci, Jooho Chung, Pedro Sanz-Altamira, Daniel J. DeAngelo, Julia E. Maxson

Blood (2021) 138 (Supplement 1): 3582.

https://doi.org/10.1182/blood-2021-148100

Published: 2021

Journal Articles

A new role for hematoxylin: targeting CALR

Julia E. Maxson

Blood (2021) 137 (14): 1848–1849.

https://doi.org/10.1182/blood.2020009852

Published: 2021

Journal Articles

FLT3 and LSD1 Inhibitor Combinations Synergistically Repress Growth of FLT3-Mutant Acute Myeloid Leukemia Via Blockage of MYC Function

Daniel J. Coleman, PhD, Brittany M. Smith, Cody Coblentz, Rowan L. Callahan, Jake VanCampen, Garth L. Kong, Brian J. Druker, MD, Julia E. Maxson, PhD, Theodore P. Braun, MDPhD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-143029

Published: 2020

Journal Articles

Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling

Sarah A Carratt, PhD BS, Theodore P. Braun, MDPhD, Zachary Schonrock, BS, Brittany M. Smith, Daniel J Coleman, PhD, Garth Kong, MS, Joseph Estabrook, MS, Adrian Baris, Lauren Maloney, Julia E. Maxson, PhD

Blood (2020) 136 (Supplement 1): 51–52.

https://doi.org/10.1182/blood-2020-143072

Published: 2020

Journal Articles

Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia

Katherine Tarlock, Todd Alonzo, Yi-Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, Tiffany Hylkema, Jenny L. Smith, Julia E. Maxson, Soheil Meshinchi

Blood (2020) 135 (18): 1603–1606.

https://doi.org/10.1182/blood.2019004179

Published: 2020

Includes: Supplemental data

Journal Articles

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Theodore Braun, MD PhD, Cody Coblentz, Sarah A Carratt, PhD BS, Mariam Okhovat, PhD, Amy Foley, MEng., Zachary Schonrock, BS, Kimberly Nevonen, Rhonda E. Ries, MA, Shannon K. McWeeney, PhD, Claus Nerlov, PhD, Soheil Meshinchi, MD PhD, Lucia Carbone, PhD, Brian J. Druker, Julia E. Maxson, PhD

Blood (2019) 134 (Supplement_1): 543.

https://doi.org/10.1182/blood-2019-124773

Published: 2019

Journal Articles

SETBP1 Mutations Accelerate NRAS-Mutant Leukemia

Sarah A Carratt, PhD BS, Zachary Schonrock, BS, Theodore Braun, MD PhD, Cody Coblentz, Amy Foley, MEng., Julia E. Maxson, PhD

Blood (2019) 134 (Supplement_1): 1254.

https://doi.org/10.1182/blood-2019-125125

Published: 2019

Journal Articles

Single Cell RNA Sequencing Identifies a Crucial Role for ASXL1 in Neutrophil Development

Theodore Braun, MD PhD, Theresa Lusardi, PhD, Trevor Enright, MS, Zachary Schonrock, BS, Cody Coblentz, Hisham Mohamed, PhD, Brian J. Druker, Julia E. Maxson, PhD

Blood (2019) 134 (Supplement_1): 212.

https://doi.org/10.1182/blood-2019-125022

Published: 2019

Journal Articles

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

Blood (2019) 134 (11): 867–879.

https://doi.org/10.1182/blood.2019000611

Published: 2019

Includes: Supplemental data

Journal Articles

Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia

Theodore Braun, MD PhD, Amy Foley, MEng., Brian J. Druker, MD, Julia E. Maxson

Blood (2018) 132 (Supplement 1): 3067.

https://doi.org/10.1182/blood-2018-99-119213

Published: 2018

Journal Articles

Distinct Mechanisms of Receptor Activation Are Associated with CSF3R Gain-of-Function Mutations

Haijiao Zhang, Julia E. Maxson, PhD, Kevin M Watanabe-Smith, PhD, Cody Coblentz, Jeffrey W. Tyner, PhD

Blood (2017) 130 (Supplement 1): 4985.

https://doi.org/10.1182/blood.V130.Suppl_1.4985.4985

Published: 2017

Journal Articles

CSF3R Mutations Synergize with CEBPA and SETBP1 Mutations in Acute Myeloid Leukemia and Chronic Neutrophilic Leukemia

Amy Foley, MEng., Seamus B Hughes, Soheil Meshinchi, MD PhD, Julia E. Maxson, PhD

Blood (2017) 130 (Supplement 1): 3963.

https://doi.org/10.1182/blood.V130.Suppl_1.3963.3963

Published: 2017

Journal Articles

Therapeutically Targetable Activating c-ABL1 Mutations in Philadelphia Chromosome-Negative Leukemias

Samantha L Savage, Julia E. Maxson, PhD, Christopher A. Eide, Chelsea Jenkins, B.S., Melissa L Abel, Anna M. Reister Schultz, Daniel Bottomly, Beth Wilmot, PhD, Shannon Mcweeney, PhD, Cristina E. Tognon, PhD, Jeffrey W. Tyner, PhD, Brian J. Druker, MD

Blood (2017) 130 (Supplement 1): 3930.

https://doi.org/10.1182/blood.V130.Suppl_1.3930.3930

Published: 2017

Journal Articles

Genomics of chronic neutrophilic leukemia

Julia E. Maxson, Jeffrey W. Tyner

Blood (2017) 129 (6): 715–722.

https://doi.org/10.1182/blood-2016-10-695981

Published: 2017

Journal Articles

A Novel CSF3R Mutation Uncovers the Importance of Membrane-Proximal N-Glycosylation for Receptor Regulation

Seamus B Hughes, David Spiciarich, Richard D. Press, Sarah L Thompson, Jerald P. Radich, Carolyn Bertozzi, Stephen T. Oh, MD PhD, Julia E. Maxson, PhD

Blood (2016) 128 (22): 3141.

https://doi.org/10.1182/blood.V128.22.3141.3141

Published: 2016

Journal Articles

PTPN11 Mutations in JMML Confer Dasatinib Sensitivity in a TNK2-Dependent Manner

Chelsea Jenkins, B.S., Samuel B Luty, BS, Julia E. Maxson, PhD, Christopher A. Eide, Bill H. Chang, MD PhD, Jeffrey W. Tyner

Blood (2016) 128 (22): 3154.

https://doi.org/10.1182/blood.V128.22.3154.3154

Published: 2016

Journal Articles

Recurrent Pathogenic Cyclin D2 Mutations in Myeloid Malignancies

Vishesh Khanna, BS, Christopher A. Eide, Cristina E. Tognon, Julia E. Maxson, PhD, Beth Wilmot, Daniel Bottomly, Shannon K. McWeeney, Brian J. Druker, MD, Jeffrey W. Tyner

Blood (2016) 128 (22): 2734.

https://doi.org/10.1182/blood.V128.22.2734.2734

Published: 2016

Journal Articles

CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML

Blood (2016) 127 (24): 3094–3098.

https://doi.org/10.1182/blood-2016-04-709899

Published: 2016

Includes: Supplemental data

NARROW

Differentiation State Plasticity As a Mechanism of BCL2 Inhibitor Resistance in Acute Myeloid Leukemia

Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R -driven myeloproliferative neoplasms

A Novel CSF3R Activating Mutation Identified in a Patient with Chronic Neutrophilic Leukemia

A new role for hematoxylin: targeting CALR

FLT3 and LSD1 Inhibitor Combinations Synergistically Repress Growth of FLT3-Mutant Acute Myeloid Leukemia Via Blockage of MYC Function

Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling

Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

SETBP1 Mutations Accelerate NRAS-Mutant Leukemia

Single Cell RNA Sequencing Identifies a Crucial Role for ASXL1 in Neutrophil Development

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia

Distinct Mechanisms of Receptor Activation Are Associated with CSF3R Gain-of-Function Mutations

CSF3R Mutations Synergize with CEBPA and SETBP1 Mutations in Acute Myeloid Leukemia and Chronic Neutrophilic Leukemia

Therapeutically Targetable Activating c-ABL1 Mutations in Philadelphia Chromosome-Negative Leukemias

Genomics of chronic neutrophilic leukemia

A Novel CSF3R Mutation Uncovers the Importance of Membrane-Proximal N-Glycosylation for Receptor Regulation

PTPN11 Mutations in JMML Confer Dasatinib Sensitivity in a TNK2-Dependent Manner

Recurrent Pathogenic Cyclin D2 Mutations in Myeloid Malignancies

CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only